§ 418-16.208. Content of stewardship plans.

A stewardship plan must fully describe a stewardship program. The plan must include all of the following:

(a)

Identification of and contact information for each participating producer.

(b)

Identification of and contact information for the person who will operate the stewardship program.

(c)

Description of a collection system that conforms to Section 418-16.214(a), including a list of all collection methods and collectors, a list of drop-off sites, a description of how any periodic take-back events will be scheduled and located, a description of how mail-back services will be provided and an example of the prepaid, preaddressed mailers that may be used.

(d)

Description of a system for transporting and disposing of the collected unwanted covered drugs that conforms to Section 418-16.216, including identification of, and contact information for, transporters and disposal facilities to be used.

(e)

Description of the policies and procedures to be followed by persons handling collected unwanted covered drugs, including a description of:

(1)

How the collected unwanted covered drugs will be safely and securely tracked from collection through final disposal;

(2)

How all persons participating in the stewardship plan will comply with all applicable federal and state laws, rules and guidelines, including but not limited to those of the U.S. Drug Enforcement Administration and State of California Board of Pharmacy.

(f)

Description of measures reasonably calculated to result in the use by county residents of the collection services to be offered under the stewardship program, such as public education and promotional materials, signage, standardized instructions and establishment of a toll-free number and website where collection options may be publicized.

(g)

The short-term and long-term goals of the stewardship program in terms of collection amounts, education, and promotion.

(h)

Description of how the stewardship program will consider:

(1)

Use of existing providers of pharmaceutical waste services;

(2)

Separation of covered drugs from packaging to the extent feasible to reduce transportation and disposal costs; and

(3)

Recycling of drug packaging to the extent feasible.

(Ord. No. 2016-24, § IV, 12-20-16)